Cargando…

Safety and efficacy of Levorag emulgel in the treatment of anal fissures using a validated scoring system

INTRODUCTION: Anal fissure is one of the most common anal disease characterized by intense anal pain, and deterioration of patients quality of life. Treatment is mainly based on the topical administration of calcium antagonist or nitric oxide ointments, and in cases refractory to medical treatment p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomasicchio, G, Dezi, A, Picciariello, A, Altomare, D. F, Giove, C, Martines, G, De Fazio, M, Rinaldi, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073417/
https://www.ncbi.nlm.nih.gov/pubmed/37035554
http://dx.doi.org/10.3389/fsurg.2023.1145170
_version_ 1785019558968426496
author Tomasicchio, G
Dezi, A
Picciariello, A
Altomare, D. F
Giove, C
Martines, G
De Fazio, M
Rinaldi, M
author_facet Tomasicchio, G
Dezi, A
Picciariello, A
Altomare, D. F
Giove, C
Martines, G
De Fazio, M
Rinaldi, M
author_sort Tomasicchio, G
collection PubMed
description INTRODUCTION: Anal fissure is one of the most common anal disease characterized by intense anal pain, and deterioration of patients quality of life. Treatment is mainly based on the topical administration of calcium antagonist or nitric oxide ointments, and in cases refractory to medical treatment patients can undergo surgery. This study aims to assess the efficacy and safety of Levorag emulgel in the treatment of acute and chronic fissures using of a validated scoring system. MATERIAL AND METHODS: A prospective observational study was carried out on patients with anal fissures between February and May 2022. The efficacy of the treatment was evaluated using the REALISE score, a new validated scoring system that rates VAS for pain, NSAID use, pain duration, bleeding, and quality of life (QoL), recorded after 10, 20 and 30 days from the beginning of treatment. RESULTS: Forty patients (median age 46 years, IQR 29–57, 70% women) with acute (22, 55%) or chronic (18, 45%) anal fissures entered the study. The median anal pain score according to the VAS scale decreased significantly from 7 (IQR 4.7–8) at baseline to 1 (IQR 0–3.2, p = 0.05) after 20 days. At the 30-day proctological examination, 22 patients (61%) were pain free (median VAS of 0, IQR 0–1.2, p < 0.05). Pain duration after defecation measured according to the REALISE score, showed a significant decrease after 10 days, from a median value of 2 (IQR 1–4) to 1 (IQR 1–1.2) (p < 0.005). The median value of the REALISE score decreased significantly, from 15 (IQR 11–19.25) at first proctological evaluation to 4 (IQR 4–6, p = 0.139) after 30 days of treatment. At day 30, complete fissure healing was achieved in 30 patients (80%). The healing rate was 82% and 78% in patients with acute and chronic anal fissures, respectively. CONCLUSION: The use of Levorag® Emulgel may represent a safe and effective non-invasive first line treatment in patients affected by acute or chronic anal fissure.
format Online
Article
Text
id pubmed-10073417
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100734172023-04-06 Safety and efficacy of Levorag emulgel in the treatment of anal fissures using a validated scoring system Tomasicchio, G Dezi, A Picciariello, A Altomare, D. F Giove, C Martines, G De Fazio, M Rinaldi, M Front Surg Surgery INTRODUCTION: Anal fissure is one of the most common anal disease characterized by intense anal pain, and deterioration of patients quality of life. Treatment is mainly based on the topical administration of calcium antagonist or nitric oxide ointments, and in cases refractory to medical treatment patients can undergo surgery. This study aims to assess the efficacy and safety of Levorag emulgel in the treatment of acute and chronic fissures using of a validated scoring system. MATERIAL AND METHODS: A prospective observational study was carried out on patients with anal fissures between February and May 2022. The efficacy of the treatment was evaluated using the REALISE score, a new validated scoring system that rates VAS for pain, NSAID use, pain duration, bleeding, and quality of life (QoL), recorded after 10, 20 and 30 days from the beginning of treatment. RESULTS: Forty patients (median age 46 years, IQR 29–57, 70% women) with acute (22, 55%) or chronic (18, 45%) anal fissures entered the study. The median anal pain score according to the VAS scale decreased significantly from 7 (IQR 4.7–8) at baseline to 1 (IQR 0–3.2, p = 0.05) after 20 days. At the 30-day proctological examination, 22 patients (61%) were pain free (median VAS of 0, IQR 0–1.2, p < 0.05). Pain duration after defecation measured according to the REALISE score, showed a significant decrease after 10 days, from a median value of 2 (IQR 1–4) to 1 (IQR 1–1.2) (p < 0.005). The median value of the REALISE score decreased significantly, from 15 (IQR 11–19.25) at first proctological evaluation to 4 (IQR 4–6, p = 0.139) after 30 days of treatment. At day 30, complete fissure healing was achieved in 30 patients (80%). The healing rate was 82% and 78% in patients with acute and chronic anal fissures, respectively. CONCLUSION: The use of Levorag® Emulgel may represent a safe and effective non-invasive first line treatment in patients affected by acute or chronic anal fissure. Frontiers Media S.A. 2023-03-22 /pmc/articles/PMC10073417/ /pubmed/37035554 http://dx.doi.org/10.3389/fsurg.2023.1145170 Text en © 2023 Tomasicchio, Dezi, Picciariello, Altomare, Giove, Martines, De Fazio and Rinaldi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Tomasicchio, G
Dezi, A
Picciariello, A
Altomare, D. F
Giove, C
Martines, G
De Fazio, M
Rinaldi, M
Safety and efficacy of Levorag emulgel in the treatment of anal fissures using a validated scoring system
title Safety and efficacy of Levorag emulgel in the treatment of anal fissures using a validated scoring system
title_full Safety and efficacy of Levorag emulgel in the treatment of anal fissures using a validated scoring system
title_fullStr Safety and efficacy of Levorag emulgel in the treatment of anal fissures using a validated scoring system
title_full_unstemmed Safety and efficacy of Levorag emulgel in the treatment of anal fissures using a validated scoring system
title_short Safety and efficacy of Levorag emulgel in the treatment of anal fissures using a validated scoring system
title_sort safety and efficacy of levorag emulgel in the treatment of anal fissures using a validated scoring system
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073417/
https://www.ncbi.nlm.nih.gov/pubmed/37035554
http://dx.doi.org/10.3389/fsurg.2023.1145170
work_keys_str_mv AT tomasicchiog safetyandefficacyoflevoragemulgelinthetreatmentofanalfissuresusingavalidatedscoringsystem
AT dezia safetyandefficacyoflevoragemulgelinthetreatmentofanalfissuresusingavalidatedscoringsystem
AT picciarielloa safetyandefficacyoflevoragemulgelinthetreatmentofanalfissuresusingavalidatedscoringsystem
AT altomaredf safetyandefficacyoflevoragemulgelinthetreatmentofanalfissuresusingavalidatedscoringsystem
AT giovec safetyandefficacyoflevoragemulgelinthetreatmentofanalfissuresusingavalidatedscoringsystem
AT martinesg safetyandefficacyoflevoragemulgelinthetreatmentofanalfissuresusingavalidatedscoringsystem
AT defaziom safetyandefficacyoflevoragemulgelinthetreatmentofanalfissuresusingavalidatedscoringsystem
AT rinaldim safetyandefficacyoflevoragemulgelinthetreatmentofanalfissuresusingavalidatedscoringsystem